We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$571M
AUM Growth
+$64.7M
Cap. Flow
+$77M
Cap. Flow %
13.5%
Top 10 Hldgs %
32.92%
Holding
757
New
120
Increased
159
Reduced
207
Closed
89

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$35.4M
2
STLA icon
Stellantis
STLA
+$22.2M
3
PEP icon
PepsiCo
PEP
+$18M
4
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$6.64M
5
KSS icon
Kohl's
KSS
+$5.18M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$21.5M
2
EIDO icon
iShares MSCI Indonesia ETF
EIDO
+$11.1M
3
ETN icon
Eaton
ETN
+$4.76M
4
DAL icon
Delta Air Lines
DAL
+$4.4M
5
WU icon
Western Union
WU
+$4.14M

Sector Composition

Rank Sector Weight
1 Financials 13.66%
2 Consumer Discretionary 12.98%
3 Consumer Staples 8.41%
4 Energy 8.01%
5 Industrials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FINX icon
226
Global X FinTech ETF
FINX
$170M
$280K 0.05%
9,500
GLW icon
227
Corning
GLW
$107B
$278K 0.05%
8,360
-7,954
-49% -$255K
DB icon
228
CALL
Deutsche Bank
DB
$66.6B
$275K 0.05%
19,409
-6,175
-24% -$47.6K
IWM icon
229
iShares Russell 2000 ETF
IWM
$79.1B
$275K 0.05%
1,766
-728
-29% -$112K
CAH icon
230
Cardinal Health
CAH
$53.7B
$269K 0.05%
5,717
-72,912
-93% -$3.36M
QCOM icon
231
Qualcomm
QCOM
$164B
$264K 0.05%
3,475
-15,804
-82% -$1.16M
BMY icon
232
Bristol-Myers Squibb
BMY
$129B
$258K 0.05%
5,691
-8,429
-60% -$393K
OGI
233
Organigram Holdings
OGI
$131M
$258K 0.05%
+10,000
New +$278K
ECL icon
234
Ecolab
ECL
$79.8B
$257K 0.05%
1,301
+1,300
+130,000% +$242K
LOW icon
235
Lowe's Companies
LOW
$121B
$255K 0.04%
2,528
-27
-1% -$2.85K
STT icon
236
State Street
STT
$48.4B
$254K 0.04%
4,525
+1,641
+57% +$102K
TRST
237
Trustco Bank Corp NY
TRST
$953M
$253K 0.04%
+6,383
New +$248K
LIT icon
238
Global X Lithium & Battery Tech ETF
LIT
$1.46B
$249K 0.04%
+9,556
New +$257K
CRBP icon
239
Corbus Pharmaceuticals
CRBP
$165M
$246K 0.04%
+1,183
New +$253K
HD icon
240
Home Depot
HD
$337B
$244K 0.04%
1,173
-262
-18% -$52.3K
IBB icon
241
iShares Biotechnology ETF
IBB
$9.45B
$243K 0.04%
2,230
ACB
242
Aurora Cannabis
ACB
$169M
$242K 0.04%
258
+220
+579% +$221K
WDC icon
243
Western Digital
WDC
$159B
$241K 0.04%
6,708
-90,480
-93% -$3.1M
TAL icon
244
TAL Education Group
TAL
$6.04B
$240K 0.04%
6,293
+6,272
+29,867% +$227K
RIG icon
245
Transocean
RIG
$5.48B
$238K 0.04%
37,161
-5,161
-12% -$38.3K
STMP
246
DELISTED
Stamps.com, Inc.
STMP
$233K 0.04%
+5,148
New +$295K
HEXO
247
DELISTED
HEXO Corp. Common Shares
HEXO
$230K 0.04%
+768
New +$284K
KMB icon
248
Kimberly-Clark
KMB
$37.6B
$228K 0.04%
1,711
-1,489
-47% -$192K
WBA
249
DELISTED
Walgreens Boots Alliance
WBA
$225K 0.04%
+4,123
New +$219K
ETN icon
250
Eaton
ETN
$141B
$223K 0.04%
2,680
-58,786
-96% -$4.76M

Similar funds

Exane Derivatives's Q2 2019 Portfolio in Review

As of Q2 2019, Exane Derivatives held 757 positions worth $571M, up 13% from $506M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Exane Derivatives deployed $77M of net new capital in Q2 2019, opening 120 new positions and adding to 159 existing holdings. Its largest new stake was Stellantis: 1,528,258 shares worth $21.6M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 7.7% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was iShares MSCI Indonesia ETF, an estimated $11.1M trimmed.

  • Exane Derivatives's largest Q2 2019 buy was Stellantis: 1,528,258 shares worth $21.6M.
  • Exane Derivatives added most to UBS Group in Q2 2019, an estimated $35.4M increase.
  • Exane Derivatives's biggest Q2 2019 reduction was iShares MSCI Indonesia ETF, cutting an estimated $11.1M.
  • Exane Derivatives fully exited Linde in Q2 2019, selling an estimated $21.5M.
  • Exane Derivatives's ten largest holdings make up 33% of its $571M portfolio in Q2 2019.
  • Exane Derivatives opened 120 new positions and closed 89 in Q2 2019.
  • Exane Derivatives's portfolio value rose 13% quarter-over-quarter to $571M.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.